Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Unsubscribe from this list.
  Pharmaceutical Technology Europe E-Alert
 
November 6, 2009
IN THIS ISSUE
Illegal equipment risk
FDA inspection disparity
100 orphan products for Europe
PTE November
More...

Illegal equipment puts pharma workers in danger
The prevalence of substandard or counterfeit safety products and personal protective equipment (PPE) has become a "very serious" problem in the UK, according to the British Safety Industry Federation (BSIF), and could be putting workers in the pharma industry at risk. More...

SOCMA petition reveals disparity of FDA inspections
The FDA has responded to a citizen petition from the Society of Chemical Manufacturers and Affiliates (SOCMA) that highlighted the disparity in inspections of domestic and foreign drug-manufacturing facilities. More...

10 new orphan products a year between 2009 and 2019
The European Organisation for Rare Diseases (EURORDIS) has predicted that 100 new designated orphan products will receive marketing authorization between 2009 and 2019, which equates to approximately 10 new products every year. More...

November issue of PTE available online
This month's issue of Pharmaceutical Technology Europe includes a special feature on pharmaceutical packaging , as well as articles on a modified Pulsincap system and sticky web technology. More...

Broken biopharm
The engine of biopharmaceutical innovation is broken, according to Eli Lilly's Chairman and CEO, John C. Lechleiter. More...

ICH prepares for global quality implementation
The International Conference on Harmonization (ICH) has adopted pharmacopeial text annexes after a meeting of the steering committee and expert working groups last week. More...

Novartis to invest $1 billion in China R&D institute
Novartis (Switzerland) plans to invest $1 billion during the next 5 years to increase R&D activities in China, including a significant expansion of The Novartis Institute of BioMedical Research (CNIBR) in Shanghai. More...

Lonza plans cost reductions
Lonza (Switzerland) has announced a series of cost-cutting measures for the next 12-–18 months. More...

USP revises excipient standards to limit contamination
In response to a request from the FDA, the US Pharmacopeial Convention (USP) has revised its standards for propylene glycol and sorbitol solution, excipients widely used in prescription and over-the-counter drugs. More...

Light-activated gold cage delivery capsule developed
A smart nanocage that can be filled with a medicinal substance and then activated using light has been developed by US researchers. More...

Product Profile
Watson Marlow
  Next day delivery on silicone tubing

USP Class VI Pumpsil silicone tubing, fully post-cured with very low leachables. Laser-etched with product code, description, lot number and use-by date for full traceability. Custom sizes to order.

Read more...

OnDemand Webcast
  Complex Documents in the Pharmaceutical Industry Made Easy

Documents are created just about everywhere in the pharmaceutical industry. To manage interrelated documents, collaboratively created and updated, versioned and published to different targets can often turn into a nightmare. With XML authoring, recurrent tasks such as applying repetitive changes to similar documents or assuring quality for cross-referencing, can finally be automated.

Read more...

Key Topic Updates
November events
Drug Delivery Partnerships (17–18 November | Czech Republic)
Active Pharmaceutical Ingredients (18–20 November | Italy)
Dissolution Testing (24–25 November | UK)
More events
 
Latest blog posts
Is Big Pharma choosing patients over patents?
Moving stem cell therapy to the clinic
Comparative effectiveness versus personalized medicine
More blog posts
 
Latest articles
Packaging: the experts' view
Trends in labeling
Developing a modified Pulsincap system
More latest articles

Key Topic Updates

Survey
Is FDA's initiative to better inform the public of what it does the right step for the agency?
  Yes 16%
  Yes, but more efforts needed 76%
  No 8%

This week we would like to know...

Are current aseptic techniques/technologies adequate to ensure patient/personnel safety?
Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.

You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.

To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, please contact us by emailing [email protected]or by mail at Advanstar Communications, Advanstar House, Park West, Sealand Road, Chester, CH1 4RN, UK.